Serum total sialic acid in differential diagnostics of jaundice caused by malignant and nonmalignant diseases: A ROC curve analysis

被引:4
作者
Cylwik, Bogdan
Chrostek, Lech
Zalewski, Bogdan
Dabrowski, Andrzej
Szmitkowski, Maciej
机构
[1] Med Univ, Dept Biochem Diagnost, PL-15269 Bialystok, Poland
[2] Med Univ, Dept Gen & Gastroenterol Surg, Bialystok, Poland
[3] Med Univ, Dept Gastroenterol & Internal Med, Bialystok, Poland
关键词
sialic acid; jaundice; diagnostic accuracy;
D O I
10.1007/s10620-006-9640-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The purpose of this study was to evaluate the usefulness of serum total sialic acid (SA) for discrimination of malignant and nonmalignant jaundice. Serum SA concentration and its ratio with total protein (SA/TP) were determined in 55 patients with jaundice: 25 malignant and 30 nonmalignant. SA was estimated by enzymatic method. Serum total SA and the ratio SA/TP were significantly higher in malignant than in nonmalignant jaundice. Diagnostic sensitivity of SA and the ratio of SA/TP in both types of jaundice reached the value of 95.8%. The specificity, positive and negative predictive values, and efficiency of SA and SA/TP were higher in malignant than in nonmalignant jaundice. Areas under ROC curves for SA and the ratio of SA/TP in malignant jaundice were higher than in nonmalignant, but there were not statistically significant differences. SA levels and the ratio of SA/TP do not have the ability to discriminate between these types of jaundice.
引用
收藏
页码:2317 / 2322
页数:6
相关论文
共 19 条
[1]   PLASMA LIPID-BOUND SIALIC-ACID ALTERATIONS IN NEOPLASTIC DISEASES [J].
DWIVEDI, C ;
DIXIT, M ;
HARDY, RE .
EXPERIENTIA, 1990, 46 (01) :91-94
[2]  
HOLMES EH, 1986, J BIOL CHEM, V261, P3737
[3]  
KATOPODIS N, 1982, CANCER RES, V42, P5270
[4]  
KOKOGLU E, 1992, CANCER BIOCHEM BIOPH, V13, P57
[5]  
NARAYANAN S, 1994, ANN CLIN LAB SCI, V24, P376
[6]   Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer [J].
Painbeni, T ;
Gamelin, E ;
Cailleux, A ;
Le Bouil, A ;
Boisdron-Celle, M ;
Daver, A ;
Larra, F ;
Allain, P .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (13) :2216-2220
[7]   Clinical usefulness of alterations in sialic acid, sialyltransferase and sialoproteins in breast cancer [J].
Raval G.N. ;
Parekh L.J. ;
Patel D.D. ;
Jha F.P. ;
Sainger R.N. ;
Patel P.S. .
Indian Journal of Clinical Biochemistry, 2004, 19 (2) :60-71
[8]   Head and neck tumours [J].
Raval, GN ;
Patel, DD ;
Parekh, LJ ;
Patel, JB ;
Shah, MH ;
Patel, PS .
ORAL DISEASES, 2003, 9 (03) :119-128
[9]  
Romppanen J, 1997, ANTICANCER RES, V17, P1249
[10]   THE UTILITY OF LIPID-ASSOCIATED SIALIC-ACID (LASA OR LSA) AS A SERUM MARKER FOR MALIGNANCY - A REVIEW OF THE LITERATURE [J].
SCHUTTER, EMJ ;
VISSER, JJ ;
VANKAMP, GJ ;
MENSDORFFPOUILLY, S ;
VANDIJK, W ;
HILGERS, J ;
KENEMANS, P .
TUMOR BIOLOGY, 1992, 13 (03) :121-132